About RainDance
RainDance is a company based in Billerica (United States) founded in 2004 was acquired by Bio Rad in January 2017. RainDance has raised $111.66 million across 17 funding rounds from investors including Myriad Genetics, General Electric and HHS. The company has 105 employees as of December 31, 2022. RainDance operates in a competitive market with competitors including GRAIL, Nanopore, PacBio, Color and Omniome, among others.
- Headquarter Billerica, United States
- Employees 105 as on 31 Dec, 2022
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Raindance Technologies, Inc. 401K Plan
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$111.66 M (USD)
in 17 rounds
-
Latest Funding Round
$16.5 M (USD), Series E
Feb 28, 2014
-
Investors
Myriad Genetics
& 10 more
-
Employee Count
105
as on Dec 31, 2022
-
Acquired by
Bio Rad
(Jan 16, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of RainDance
RainDance has successfully raised a total of $111.66M across 17 strategic funding rounds. The most recent funding activity was a Series E round of $16.5 million completed in February 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in RainDance
RainDance has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Myriad Genetics, General Electric and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Northgate Capital is engaged in venture capital and private equity investments.
|
Locked | Locked | Locked | |
|
CRG is recognized as a premier healthcare investment partner.
|
Locked | Locked | Locked | |
|
Venture capital investments are managed in technology and healthcare sectors by this firm.
|
Locked | Locked | Locked |
Investor details for RainDance
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RainDance
Investment portfolio details for RainDance
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RainDance
Detailed financials for RainDance
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Raindance Comparisons
Peer comparison for RainDance
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RainDance
RainDance operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GRAIL, Nanopore, PacBio, Color and Omniome, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Circulating tumor DNA is screened for early cancer detection.
|
|
| Locked | Locked | Locked |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| Locked | Locked | Locked |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| Locked | Locked | Locked |
Cancer care is delivered through a virtual clinic by Color.
|
|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
DNA sequencing platform for human genome analysis is developed.
|
Detailed competitors of RainDance
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Raindance
Complete news archive for RainDance
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RainDance
RainDance was founded in 2004 and raised its 1st funding round 2 years after it was founded.
RainDance is headquartered in Billerica, United States. It is registered at Billerica, Massachusetts, United States.
Kathy Ordonez is the current CEO of RainDance.
RainDance is a funded company, having raised a total of $111.66M across 17 funding rounds to date.
As of Dec 31, 2022, the latest employee count at RainDance is 105.
RainDance was founded in 2004 in Billerica, United States, within the biotechnology sector. Nucleic acid detection and quantification systems are developed, manufactured, and sold based on proprietary single-molecule PCR technology, which processes reactions in millions of uniform 5-picoliter droplets for enhanced sensitivity and specificity compared to traditional methods. A next-generation sequencing target enrichment system is also offered, including instrumentation and pre-validated gene panels.
RainDance has 11 investors. Key investors include Myriad Genetics, General Electric, HHS, Bio Rad, and Northgate Capital.